In vitro antifungal activity of isavuconazole against 345 mucorales isolates collected at study centers in eight countries

P. E. Verweij, G. M. González, N. P. Wiederhold, C. Lass-Flörl, P. Warn, Markus Heep, M. A. Ghannoum, J. Guinea

Research output: Contribution to journalArticle

57 Scopus citations

Abstract

Although mucormycoses (formerly zygomycoses) are relatively uncommon, they are associated with high mortality and treatment options are limited. Isavuconazole is a novel, water soluble, broad-spectrum azole in clinical development for the treatment of invasive aspergillosis and candidiasis. The objective of this report was to collate data on the in vitro activity of isavuconazole against a collection of 345 diverse Mucorales isolates, collected and tested at eight study centers in Europe, Mexico and North America. Each study center undertook minimum inhibitory concentration (MIC) susceptibility testing of their isolates, according to EUCAST or CLSI guidelines. Across all study centers, isavuconazole exhibited MIC50 values of 1-4 mg/L and MIC90 values of 4-16 mg/L against the five genera. There were also marked differences in MIC distributions, which could be ascribed to differences in inoculum and/or endpoint. EUCAST guidelines appeared to generate modal MICs 2-fold higher than CLSI. These results confirm that isavuconazole possesses at least partial antifungal activity against Mucorales.

Original languageEnglish (US)
Pages (from-to)272-281
Number of pages10
JournalJournal of Chemotherapy
Volume21
Issue number3
DOIs
StatePublished - Jun 2009

Keywords

  • CLSI
  • EUCAST
  • Isavuconazole
  • MIC
  • Mucorales
  • Mucormycoses
  • Zygomycetes
  • Zygomycosis

ASJC Scopus subject areas

  • Oncology
  • Pharmacology
  • Pharmacology (medical)
  • Infectious Diseases

Fingerprint Dive into the research topics of 'In vitro antifungal activity of isavuconazole against 345 mucorales isolates collected at study centers in eight countries'. Together they form a unique fingerprint.

  • Cite this

    Verweij, P. E., González, G. M., Wiederhold, N. P., Lass-Flörl, C., Warn, P., Heep, M., Ghannoum, M. A., & Guinea, J. (2009). In vitro antifungal activity of isavuconazole against 345 mucorales isolates collected at study centers in eight countries. Journal of Chemotherapy, 21(3), 272-281. https://doi.org/10.1179/joc.2009.21.3.272